Jeffrey Kraft

5PUBLICATIONS
75CO-AUTHORS
Molecular targetsMolecular medicineAvionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2026
FDA Approval Summary: Erdafitinib for FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma.

|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.

Sonia Singh, Diana Bradford, Somak Chatterjee

|Oct 30, 2024
FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation.

Ashley C Woods, Kelly J Norsworthy, Moran Choe

|Aug 25, 2023
FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum.

Sonia Singh, Diana Bradford, Xiaoxue Li

|Jun 02, 2023
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.

Elizabeth S Duke, Diana Bradford, Michelle Marcovitz

Pageof 1